Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Jabak Visited Marjayoun Hospital to Improve the Health Services and Conditions of the Governmental Hospitals in Disadvantaged Areas

 
Minister of Public Health Dr. Jamil Jabak visited Marjayoun Governmental Hospital in Jdeidet Marjayoun to improve the health care and medical services in Marjayoun District, completing his tour of governmental hospitals in the disadvantaged areas.

Jabak toured the hospital’s departments with the chairman of the board of directors and the director general Dr. Moueness Kalakech who briefed him on the medical services the hospital provides to the citizens coming from different villages in South Lebanon. Dr. Kalakech also informed Minister Jabak of the needs of the hospital as to the medical equipment. Jabak met with a number of patients in the hospital and visited the intensive care and cardiology departments.

Jabak then visited the new building that was constructed in 2016 before he held a press conference in Kalakech’s Office at the hospital.
“Marjayoun Hospital is an example of coexistence. Although it is a small hospital with 60 beds only, however it has great potential and highly qualified doctors,” Jabak stated.

The Hospital’s Director Dr. Moueness Kalakech briefed Minister Jabak on the medical services provided by Marjayoun Hospital, praising the major role of Speaker Nabih Berri and his support to the hospital.
    ...
    170
    ...
ATC Name B/G Ingredients Dosage Form Price
J06BA02 CLAIRYG BioHuman Human normal immunoglobulin G - 50mg/ml 5g/100ml Injectable solution L.L
J06BA02 KIOVIG BioHuman Human normal immunoglobulin G - 5g/50ml 5g/50ml Injectable solution 35,639,835 L.L
J06BA02 OCTAGAM 10% BioHuman Human normal immunoglobulin G - 10% 5g/50ml Injectable solution 37,672,334 L.L
J06BA02 KIOVIG BioHuman Human normal immunoglobulin G - 5g/50ml 5g/50ml Injectable solution L.L
G02AX GYNOCIN G Oxytocin - 5IU/0.5ml 5IU/0.5ml Injectable concentrate for solution 313,115 L.L
A05AA04 OCALIVA B Obeticholic acid - 5mg 5mg Tablet, film coated 224,503,943 L.L
G03DC02 PRIMOLUT NOR B Norethisterone acetate - 5mg 5mg Tablet 296,989 L.L
C09AA04 COVERSYL ARGININE B Perindopril arginine - 5mg 5mg Tablet, film coated 452,875 L.L
A06AB02 DULCOLAX B Bisacodyl - 5mg 5mg Tablet, sugar coated 520,067 L.L
N05AH03 ZYPREXA B Olanzapine - 5mg 5mg Tablet 1,197,364 L.L
A06AB02 DULCOLAX B Bisacodyl - 5mg 5mg Tablet, sugar coated 219,046 L.L
N05AH03 ZYPREXA B Olanzapine - 5mg 5mg Tablet 1,197,364 L.L
L04AD02 PROGRAF 5MG B Tacrolimus - 5mg 5mg Capsule 94,286,686 L.L
N05AH03 OLANZAMED G Olanzapine - 5mg 5mg Tablet 665,522 L.L
L04AD02 PROGRAF 5MG B Tacrolimus - 5mg 5mg Capsule 94,286,686 L.L
N05AH03 OLANZAPINE ARROW G Olanzapine - 5mg 5mg Tablet 670,577 L.L
L04AD02 TACROGRAF 5 G Tacrolimus - 5mg 5mg Capsule 67,507,154 L.L
N05AH03 PREXAL 5 G Olanzapine - 5mg 5mg Caplet, film coated 718,956 L.L
N05AH03 ZYPREXA VELOTAB B Olanzapine - 5mg 5mg Tablet, dispersible 2,607,054 L.L
C09AA05 TRITACE B Ramipril - 5mg 5mg Tablet 509,316 L.L
N05AH03 ZYPREXA VELOTAB B Olanzapine - 5mg 5mg Tablet, dispersible 2,607,054 L.L
C09AA05 ACURIL G Ramipril - 5mg 5mg Tablet 614,136 L.L
N05AH03 APO-OLANZAPINE ODT G Olanzapine - 5mg 5mg Tablet, orally disintegrating 1,463,444 L.L
C09AA05 APO-RAMIPRIL G Ramipril - 5mg 5mg Capsule 794,211 L.L
N05AH03 OLANZAPINE ARROW G Olanzapine - 5mg 5mg Tablet, orodispersible 1,385,502 L.L
C09AA05 NORMOPRIL G Ramipril - 5mg 5mg Tablet 474,376 L.L
N05AH03 OLANZAX 5 G Olanzapine - 5mg 5mg Tablet, mouth dissolving 1,316,966 L.L
C09AA05 RAMIPRIL-REMEDICA G Ramipril - 5mg 5mg Tablet 623,543 L.L
N05AH03 PRANZA G Olanzapine - 5mg 5mg Tablet, orodispersible 1,773,872 L.L
C09AA05 TRILTEC G Ramipril - 5mg 5mg Capsule 447,948 L.L
    ...
    170
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2026